Identification of RNA aptamer specific to mutant KRAS protein

Oligonucleotides

Volumn 20, Issue 3, 2010, Pages 155-161

  Jeong, Sujin ^a   Han, Seung Ryul ^a   Lee, Young Ju ^a   Kim, Ju Hyun ^a   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APTAMER; GUANOSINE TRIPHOSPHATE; K RAS PROTEIN; MUTANT PROTEIN; RNA; CODON; PRIMER DNA;

ARTICLE; BINDING AFFINITY; CODON; COMBINATORIAL CHEMISTRY; GENE IDENTIFICATION; HUMAN; ONCOGENE K RAS; POINT MUTATION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; WILD TYPE; CHEMISTRY; CONFORMATION; GENETICS; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; POLYMERASE CHAIN REACTION;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CODON; DNA PRIMERS; GENES, RAS; NUCLEIC ACID CONFORMATION; POINT MUTATION; POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE;

EID: 77954097134     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2010.0231     Document Type: Article

References (29)

1. BAE, S.J., OUM, J.H., SHARMA, S., PARK, J., and LEE, S.W. (2002). In vitro selection of specific RNA inhibitors of NFATc. Biochem. Biophys. Res. Comm. 298, 486-492.
2. BRUMMELKAMP, T.R., BERNARDS, R., and AGAMI, R. (2002). Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247.
3. CAMPBELL, S.L., KHOSRAVI-FAR, R., ROSSMAN, K.L., CLARK, G.J., and DER, C.J. (1998). Increasing complexity of Ras signaling. Oncogene 17, 1395-1413.
4. CHO, J.S., and LEE, S.W. (2009). Sequence and structural features of RNA aptamer against myasthenic autoantibodies. Oligonucleotides 19, 273-279.
5. DOWNWARD, J. (2003). Targeting RAS signaling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
6. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
7. FRIDAY, B.B., and ADJEI, A.A. (2005). K-ras as a target for cancer therapy. Biochim. Biophys. Acta 1756, 127-144.
8. HANCOCK, J.F. (2003). Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell. Biol. 4, 373-384.
9. HWANG, B., and LEE, S.W. (2002). Improvement of RNA ap-tamer activity against myasthenic autoantibodies by extended sequence selection. Biochem. Biophys. Res. Commum. 290, 656-662.
10. HWANG, B., CHO, J.S., YEO, H.J., KIM, J.H., CHUNG, K.M., HAN, K., JANG, S.K., and LEE, S.W. (2004). Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10, 1277-1290.
11. HWANG, B., LIM, J.H., HAHM, B., JANG, S., and LEE, S.W. (2009). hnRNP L is required for the translation mediated by HCV IRES. Biochem. Biophys. Res. Commun. 378, 584-588.
12. JACKSON, E.L., WILLIS, N., MERCER, K., BRONSON, R.T., CROWLEY, D., MONTOYA, R., JACKS, T., and TUVESON, D.A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248.
13. JACKSON, J.H., LI, J.W., BUSS, J.E., DER, C.J., and CO-CHRANE, C.G. (1994). Polylysine domain of K-ras 4B protein is crucial for maliganant transformation. Proc. Natl. Acad. Sci. U.S.A. 91, 12730-12734.
14. JOHNSON, L., GREENBAUM, D., CICHOWSKI, K., MERCER, K., MURPHY, E., SCHMITT, E., BRONSON, R.T., UMANOFF, H., EDELMANN, W., KUCHERLAPATI, R., and JACKS, T. (1997). K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11, 2468-2481.
15. JOHNSON, L., MERCER, K., GREENBAUM, D., BRONSON, R.T., CROWLEY, D., TUVESON, D.A., and JACKS, T. (2001). Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116.
16. KAUR, G., and ROY, I. (2008). Therapeutic applications of ap-tamers. Expert Opin. Investig. Drugs 17, 43-60.
17. KIMOTO, M., SHIROUZU, M., MIZUTANI, S., KOIDE, H., KAZIRO, Y., HIRAO, I., and YOKOYAMA, S. (2002). Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation. Eur. J. Biochem. 269, 697-704.
18. KURTZ, S.E., ESPOSITO, K., TANG, W., and MENZEL, R. (2003). Inhibition of an activated Ras protein with genetically selected peptide aptamers. Biotechnol. Bioeng. 82, 38-46.
19. LEE, S.W., and SULLENGER, B. (1996). Isolation of a nuclease resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes. J. Exp. Med. 194, 315-324.
20. LEE, S.W., and SULLENGER, B. (1997). Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat. Biotechnol. 15, 41-45.
21. LOWY, D.R., and WILLUMSEN, B.S. (1993). Function and regulation of ras. Annu. Rev. Biochem. 62, 851-891.
22. MARGARIT, S.M., SONDERMANN, H., HALL, B.E., NAGAR, B., HOELZ, A., PIRRUCCELLO, M., BAR-SAGI, D., and KURIYAN, J. (2003). Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112, 685-695.
23. McCORMICK, F. (1989). ras GTPase activating protein: signal transmitter and signal terminator. Cell 56, 5-8.
24. PINCUS, M.R. (2004). Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins. Front. Biosci. 9, 3486-3509.
25. QUE-GEWIRTH, N.S., and SULLENGER, B.A. (2007). Gene therapy progress and prospects: RNA aptamers. Gene Ther. 14, 283-291.
26. SANTOS, E., and NEBREDA, A.R. (1989). Structural and functional properties of ras proteins. FASEB J. 3, 2151-2163.
27. TANAKA, T., AKAGI, K., NAKAMURA, Y., and KOZU, T. (2007). RNA aptamers targeting the carboxyl terminus of KRAS oncoprotein generated by an improved SELEX with isothermal RNA amplification. Oligonucleotides 17, 12-21.
28. TUERK, C., and GOLD, L. (1990). Systematic evolution of li-gands by exponential enrichment: RNA ligands to bacterio-phage T4 DNA polymerase. Science 249, 505-510.
29. ZUKER, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.